VHT is attracting unusual short-side attention heading into mid-May, with borrowed shares nearly doubling over the past week against a sector backdrop where ETF money is quietly walking out the door.
The most notable development this week is a sharp jump in short positioning. Estimated short shares rose 116% over the past seven days, reaching around 193,000 shares on May 12 — more than double the roughly 89,000 that had been sitting relatively stable through the first week of May. That kind of move in a broad-market healthcare ETF is uncommon. The ORTEX short score has also drifted higher, reaching 27.4 on May 12 from 25.7 a week earlier, still low in absolute terms but tracking in the wrong direction. Days to cover remain minimal at around one day per the latest FINRA fortnightly data, so the short book is not deeply entrenched — but the acceleration in the past two sessions is worth noting.
The lending market has tightened alongside the positioning shift, though conditions remain loose by most standards. Cost to borrow climbed to 0.71% on May 12, up from 0.44% a week prior — a 53% week-on-week jump, and the highest reading in roughly six weeks. Availability is still ample. The borrow market is nowhere near stressed: the 52-week utilization peak was 47%, and the current reading barely registers at 2.1%. The put/call ratio has edged above its recent average as well, running at 0.64 versus a 20-day mean of 0.59 — about 1.2 standard deviations elevated — consistent with modest hedging but far from the extreme defensive postures the fund has seen; the 52-week PCR high was 2.74, so options positioning remains relaxed in historical context.
The sector flow backdrop offers context for the short-side activity. Healthcare ETFs logged net outflows of roughly $170 million over the past week, making the sector one of only a handful with negative flows. Flow imbalance sits at 47.4, among the softer readings across all sectors, versus Information Technology's dominant 56.8. That backdrop is consistent with some investors trimming healthcare exposure — and those hedging a long healthcare book via VHT shorts as an overlay. Meanwhile, individual healthcare names drawing attention this week include ABBV comments on the obesity market and analyst activity around CVS, where Bernstein raised its target to $106. GLP-1 names like LLY continue to generate headlines. The patchwork of sector-level news suggests healthcare sentiment is active but divided, rather than in outright retreat.
Institutional holders appear broadly stable. Morgan Stanley remains the largest reported holder at roughly 1.9% of shares as of December 2025, with UBS and PGIM also carrying meaningful positions. None of the top 15 holders showed dramatic moves in recent filings. The fund paid a $0.994 dividend in March 2026, its most recent distribution on record.
The price action itself is muted. VHT closed at $272.93 on May 12, up 1.9% on the day but essentially flat on the week, and down just 0.3% over the past month. The short build sits against a fund that hasn't moved much — which makes the direction of the short interest over the next several sessions the key thing to watch.
See the live data behind this article on ORTEX.
Open VHT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
